BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24034420)

  • 1. Increased N-terminal cleavage of alpha-2-antiplasmin in patients with liver cirrhosis.
    Uitte de Willige S; Malfliet JJ; Janssen HL; Leebeek FW; Rijken DC
    J Thromb Haemost; 2013 Nov; 11(11):2029-36. PubMed ID: 24034420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of fibrinolysis by inhibiting enzymatic cleavage of precursor α2-antiplasmin.
    Lee KN; Jackson KW; Christiansen VJ; Dolence EK; McKee PA
    J Thromb Haemost; 2011 May; 9(5):987-96. PubMed ID: 21251197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion.
    Lee KN; Jackson KW; Christiansen VJ; Chung KH; McKee PA
    Blood; 2004 May; 103(10):3783-8. PubMed ID: 14751930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein.
    Lee KN; Jackson KW; Christiansen VJ; Lee CS; Chun JG; McKee PA
    Blood; 2006 Feb; 107(4):1397-404. PubMed ID: 16223769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of soluble fibroblast activation protein in arterial thrombosis: determinants and cleavage of its substrate alpha-2-antiplasmin.
    Uitte de Willige S; Malfliet JJ; Deckers JW; Dippel DW; Leebeek FW; Rijken DC
    Int J Cardiol; 2015 Jan; 178():105-10. PubMed ID: 25464232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using substrate specificity of antiplasmin-cleaving enzyme for fibroblast activation protein inhibitor design.
    Lee KN; Jackson KW; Terzyan S; Christiansen VJ; McKee PA
    Biochemistry; 2009 Jun; 48(23):5149-58. PubMed ID: 19402713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and characterization of monoclonal antibodies against the N-terminus of alpha-2-antiplasmin.
    Abdul S; Peeters M; Brouwers E; Malfliet JJMC; Leebeek FWG; Declerck PJ; Rijken DC; Uitte de Willige S
    PLoS One; 2018; 13(5):e0196911. PubMed ID: 29723259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic and genetic variation of the alpha-2-antiplasmin C-terminus in myocardial infarction.
    Uitte de Willige S; Miedzak M; Carter AM; Lisman T; Rosendaal FR; Grant PJ; Philippou H; Ariëns RA
    Blood; 2011 Jun; 117(24):6694-701. PubMed ID: 21505192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why alpha-antiplasmin must be converted to a derivative form for optimal function.
    Lee KN; Jackson KW; Christiansen VJ; Lee CS; Chun JG; McKee PA
    J Thromb Haemost; 2007 Oct; 5(10):2095-104. PubMed ID: 17883704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The level of circulating fibroblast activation protein correlates with incorporation of alpha-2-antiplasmin into the fibrin clot.
    Uitte de Willige S; Malfliet JJCM; Abdul S; Leebeek FWG; Rijken DC
    Thromb Res; 2018 Jun; 166():19-21. PubMed ID: 29649768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types I, III, and IV.
    Christiansen VJ; Jackson KW; Lee KN; McKee PA
    Arch Biochem Biophys; 2007 Jan; 457(2):177-86. PubMed ID: 17174263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the localization of the cleavage site in human alpha-2-antiplasmin, involved in the generation of the non-plasminogen binding form.
    Abdul S; Dekkers DHW; Ariëns RAS; Leebeek FWG; Rijken DC; Uitte de Willige S
    J Thromb Haemost; 2020 May; 18(5):1162-1170. PubMed ID: 32034861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural heterogeneity of α2-antiplasmin: functional and clinical consequences.
    Abdul S; Leebeek FW; Rijken DC; Uitte de Willige S
    Blood; 2016 Feb; 127(5):538-45. PubMed ID: 26626994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis.
    Leebeek FW; Kluft C; Knot EA; de Maat MP; Wilson JH
    Gastroenterology; 1991 Nov; 101(5):1382-90. PubMed ID: 1718809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The alpha-2-antiplasmin Arg407Lys polymorphism is associated with abdominal aortic aneurysm.
    Bridge KI; Macrae F; Bailey MA; Johnson A; Philippou H; Scott DJ; Ariens RA
    Thromb Res; 2014 Sep; 134(3):723-8. PubMed ID: 25065555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha2-antiplasmin: potential therapeutic roles in fibrin survival and removal.
    Lee KN; Jackson KW; Christiansen VJ; Chung KH; McKee PA
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Oct; 2(4):303-10. PubMed ID: 15320781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of a single nucleotide polymorphism on human alpha 2-antiplasmin activity.
    Christiansen VJ; Jackson KW; Lee KN; McKee PA
    Blood; 2007 Jun; 109(12):5286-92. PubMed ID: 17317851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of phenylglyoxal-modified alpha2-antiplasmin on urokinase-induced fibrinolysis.
    Lee KN; Lee SC; Jackson KW; Tae WC; Schwartzott DG; McKee PA
    Thromb Haemost; 1998 Oct; 80(4):637-44. PubMed ID: 9798984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating concentrations of fibroblast activation protein α in apparently healthy individuals and patients with acute coronary syndrome as assessed by sandwich ELISA.
    Tillmanns J; Widera C; Habbaba Y; Galuppo P; Kempf T; Wollert KC; Bauersachs J
    Int J Cardiol; 2013 Oct; 168(4):3926-31. PubMed ID: 23932048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of a sequence from alpha2-antiplasmin transforms human serum albumin into a blood clot component that speeds clot lysis.
    Sheffield WP; Eltringham-Smith LJ; Gataiance S; Bhakta V
    BMC Biotechnol; 2009 Mar; 9():15. PubMed ID: 19257897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.